| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |